Drug Shortage Report for FOSRENOL
| Report ID | 115725 |
| Drug Identification Number | 02287145 |
| Brand name | FOSRENOL |
| Common or Proper name | Fosrenol Tablets 250mg |
| Company Name | TAKEDA CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | LANTHANUM |
| Strength(s) | 250MG |
| Dosage form(s) | TABLET (CHEWABLE) |
| Route of administration | ORAL ORAL |
| Packaging size | 90 Tablets |
| ATC code | V03AE |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2020-05-25 |
| Estimated end date | 2021-02-15 |
| Actual end date | 2021-02-05 |
| Shortage status | Resolved |
| Updated date | 2021-02-12 |
| Company comments | Constrained supply with product allocation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-05-25 | English | Compare |